Neuronikinin, otherwise known as EP-107560 or EZM-3 ("Element Zero Mimetic-3"), is an orally-bioavailable small-molecule chemical compound that serves as a mimetic to element zero in neuronal reprogramming. It was synthesized and characterized by the Alliance Intelligence Service and Ellis Pharmaceuticals under the Paragon Project.